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Understanding the mechanisms regulating expression of retinal ganglion cell (RGC) speciﬁc and axon-
guidance genes during development and in retinal stem cells will be critical for successful optic nerve
regeneration. Müller glia have some characteristics of retinal stem cells but in mammals have demon-
strated limited potential to differentiate into RGCs. Chromatin remodeling through histone deacetylation
and DNA methylation are a potential mechanism for silencing genes necessary for neuronal differentia-
tion of glial cells. We investigated DNA methylation as a mechanism for regulating expression of mouse
EphA5, one member of a large family of ephrin receptor genes that regulate patterning of the topographic
connections of RGCs during visual system development. We analyzed spatial and age-related patterns of
EphA5 promoter methylation by bisulﬁte sequencing and mRNA expression by quantitative RT-PCR in the
mouse retina. The CpG island in the EphA5 promoter was hypomethylated in the retina and showed no
change in overall methylation with age, despite a decline in EphA5 mRNA expression levels in the adult
retina. In the nasal retina of post-natal day 0 mice, there was a modest, but statistically signiﬁcant
increase in methylation. Increased methylation corresponded with lower levels of receptor mRNA expres-
sion in the nasal retina. We cloned the EphA5 promoter and found that site-speciﬁc differences in meth-
ylation could preferentially activate or repress promoter activity in transient transfections of rat retinal
progenitor cells (R28) using luciferase assays. In sphere cultures generated by EGF/FGF2 stimulation of
conditionally immortalized mouse Müller glia (ImM10), EphA5 promoter was hypermethylated and
EphA5mRNA was not detected. Demethylation using 5-azadeoxycytidine (AzadC) resulted in a signiﬁcant
decrease of methylation of the EphA5 promoter and re-expression of the EphA5 mRNA. The inverse rela-
tionship between EphA5 promoter methylation and mRNA expression is consistent with a role for DNA
methylation in modulating the spatial patterns of EphA5 gene expression in the retina and in silencing
EphA5 expression in ImM10 cells. The robust up-regulation of EphA5 in ImM10 cells following demeth-
ylation suggests that modulation of chromatin structure may be a useful approach for promoting expres-
sion of silenced developmental genes and increasing the neurogenic potential of Müller glia.
 2010 Elsevier Ltd. All rights reserved.1. Introduction mammals, the retina and optic nerve do not regenerate. However,Currently there are no cures for neurodegenerative diseases that
affect the optic nerve. Even if progression can be stopped, there is a
need to develop regenerative therapies to restore lost vision. Inll rights reserved.
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.edu (D.C. Otteson).in teleost ﬁsh, Müller glia are the source of the retinal stem cells in
the inner retina that generate rod photoreceptors during normal
growth and can regenerate all classes of retinal neurons including
RGCs following injury (Bernardos, Barthel, Meyers, & Raymond,
2007; Otteson, D’Costa, & Hitchcock, 2001). The robust neurogenic
capacity of Müller glia in ﬁsh and, to a more limited extent, in birds
(Fischer & Reh, 2003) has stimulated research to understand the
stem cell properties and neurogenic potential of Müller glia in the
mammalian retina both in vivo and in vitro (Bhatia, Singhal,
Lawrence, Khaw, & Limb, 2009; Dyer & Cepko, 2000; Karl et al.,
2008; Ooto et al., 2004; Wohl, Schmeer, Kretz, Witte, & Isenmann,
2009). The challenges for developing cell-replacement strategies to
treat optic neuropathies will require not only identifying how to
regenerate retinal ganglion cells (RGCs), but also how to promote
T.D. Petkova et al. / Vision Research 51 (2011) 260–268 261axon growth and connectivity. For functional vision, the spatial rela-
tionship betweenneighboring retinal ganglion cells (RGC) in the ret-
ina must be preserved in the topographic organization of their
synaptic connections in the visual centers of the brain. In the visual
system, forward and reverse signaling through Ephrin receptors
(Eph) and ephrin ligands functions as chemoafﬁnity signals that reg-
ulate retinotopic mapping.
Eph receptors constitute a familyof tyrosinekinase receptors that
regulatemultiple aspects of development anddisease includingvas-
cular development (Zhang & Hughes, 2006) and synaptogenesis
(Murai & Pasquale, 2004; Otal, Burgaya, Frisen, Soriano, &Martinez,
2006). More recently, disregulation of EPH/ephrin signaling has also
been implicated in oncogenesis and tumor progression
(Merlos-Suarez & Batlle, 2008). However, one of their most well
known functions is in patterning the formation of sensory maps in
the central nervous system during development (Scicolone, Ortalli,
& Carri, 2009). In the visual system, gradients of Eph receptors along
the nasal/temporal and dorsal/ventral axes of the retina respond to
corresponding gradients of ephrin ligands in target regions within
the brain to create the positional information that guides the initial
spatial organization of RGC connectivity (Feldheim et al., 2004;
Flanagan, 2006; Scicolone et al., 2009). In the mouse retina, EphA5
is expressed in an increasing nasal to temporal gradient and
functions in patterning the location of retinal axon termination
along the anterior–posterior axis in the visual centers in the brain.
In the mouse retina, EphA5 expression is initiated during the optic
vesicle stage. By E11, when the ﬁrst retinal ganglion cells begin to
differentiate, EphA5 expression in the neuroblastic layer andnascent
RGCs extends in a temporal (high) to nasal (low) gradient across the
optic cup (Cooper, Crockett, Nowakowski, Gale, & Zhou, 2009). Axon
outgrowth begins at E12 and by E17, RGCs have projected through
the optic tract and have begun to reach targets and arborize in the
ventral lateral geniculate nucleus and superior colliculus (Bovolenta
& Mason, 1987; Godement, Salaun, & Imbert, 1984). Graded EphA5
expression is prominent in the inner retina and RGC layer beginning
at E12, and by E17.5, when all RGCs have been generated, the gradi-
ent of EphA5 is robust in theRGC layer (Cooper et al., 2009). ByP0, the
retinal ganglion cells ﬁbers have established their terminal connec-
tions, but have not yet entered the subsequent period of connection
reﬁnement. Although the gradient of EphA5 expression persists in
the ganglion cell layer in the adult retina, there is a gradual decline
in overall expression and a ﬂattening of the gradient with age
(Rodger et al., 2001). Loss of EphA5 receptor leads to mapping
abnormalities along the anterior/posterior axis of the mouse supe-
rior colliculus (Feldheim et al., 2004) conﬁrming the importance of
the receptor in the positional termination of retinal axons.
While there is extensive literature showing direct regulation of
EphB receptors by transcription factors (reviewed by (Petros,
Rebsam, & Mason, 2008), little is known about transcriptional
mechanisms regulating EphA5 expression in the retina. Hmx family
transcription factors, SOHO and GH6, have been implicated in reg-
ulation of EphA3 expression in chick (Schulte & Cepko, 2000) and,
in the developing mouse retina, Hmx1 is expressed in a nasal
high/temporal low gradient (Wang, Lo, Frasch, & Lufkin, 2000).
However, the role of Hmx1 in regulating EphA5 expression in the
mouse retina has not been determined. FoxD1 and FoxG1 are
expressed in reciprocal gradients in the developing mouse retina
(Hatini, Tao, & Lai, 1994) and regulate formation of the contralat-
eral and ipsilateral pathways and optic chiasm in the mouse
(Herrera et al., 2004; Pratt, Tian, Simpson, Mason, & Price, 2004;
Tian, Pratt, & Price, 2008). However, only EphB1 has been proposed
as a downstream target of FOX transcription factors in the mouse
retina and the speciﬁc transcription factors that regulate EphA5
expression in the retina have not been determined.
DNA methylation is an epigenetic mechanism for regulating
gene transcription in embryonic stem cells during differentiationand development (Yeo et al., 2007) and increased DNAmethylation
of CpG islands is associated with gene silencing (Bird, 2002). Ex-
cept in oocytes and cancer, hypermethylation has typically been
thought of as an irreversible chromatin modiﬁcation. However,
several studies have shown that demethylation of cell-type speciﬁc
genes is dynamic (Frank et al., 1990; Meissner et al., 2008; Song
et al., 2009). During development, 2% of the CpG islands that are
methylated in embryonic stem cells become demethylated in neu-
ral progenitors (Meissner et al., 2008). All of the Eph receptor genes
contain CpG islands within their proximal promoters and hypo-
and hypermethylation can alter Eph receptor expression in cancer.
Hypermethylation down-regulates EphA3 in hematopoietic tumors
(Dottori, Down, Huttmann, Fitzpatrick, & Boyd, 1999) and EphA7 in
colon cancer (Wang et al., 2005) and increased methylation of
EphA5 is correlated with decreased expression in primary breast
cancer (Fu et al.). Conditional knockout of Dnmt1, the maintenance
DNA methyltransferase, in mouse neural progenitors resulted in
increased differentiation of astroglia in the mouse brain, indicating
a role for DNA methylation in the switch from neurogenesis to
gliogenesis.
Recent transcriptome analysis has revealed that Müller glia ex-
press many, but not all of the same genes expressed by undifferen-
tiated retinal progenitor cells in the embryonic retina (Roesch
et al., 2008). In the mature retina in mammals, some Müller glia
proliferate in the context of retinal injury or disease in vivo and a
fraction up-regulate genes characteristic of differentiated retinal
neurons (Dyer & Cepko, 2000; Karl et al., 2008; Wohl, Schmeer,
Kretz, Witte, & Isenmann, 2009). Cultured Müller glia from human
(Lawrence et al., 2007), rat (Kubota, Nishida, Nakashima, & Tano,
2006) and mouse (Das et al., 2006; Otteson & Phillips, 2010;
Phillips, Guirguis, Beach, Pillai, & Otteson, 2008) show stem cell
characteristics, including expression of multiple retinal stem cell
genes and formation of proliferating neurospheres in response to
epidermal growth factor (EGF) and ﬁbroblast growth factor 2
(FGF2). However, Müller-derived cells are quite limited in their
neurogenic potential both in vivo and in vitro, and only a fraction
acquire neuronal characteristics or up-regulate genes characteris-
tic of differentiated retinal neurons. Single cell microarray analysis
of gene expression showed that many key genes that regulate ret-
inal ganglion cell development and differentiation, including Atoh7,
Pou4F2, Isl2 and EphA5, were either not expressed or expressed at
low levels only in a subset of Müller glia cells examined (Roesch
et al., 2008).
Understanding the mechanisms that regulate expression of key
genes involved in RGC developmental and axon guidance in the
retina and in Müller glia will contribute to the development of
regenerative therapies to restore the optic nerve and vision in pa-
tients with glaucoma. We describe here the cloning of the mouse
EphA5 promoter and address the potential role of DNA methylation
in regulating EphA5 expression in the mouse retina in vivo and in
conditionally immortalized Müller glia (ImM10 cell line) in vitro.2. Materials and methods
2.1. Cell culture
The following cell lines were used: the R28 rat retinal progeni-
tor cell line (Seigel, 1996) and the ImM10 conditionally immortal-
ized Müller glia cell line (Otteson & Phillips, 2010). R28 cells were
cultured in DMEM (Sigma; St. Louis, MO) supplemented with
1.125% sodium bicarbonate, 10% calf serum, 1% each MEM non-
essential amino acids and MEM vitamins, 2 mM L-glutamine and
0.1 mg/ml gentamicin. ImM10 cells were cultured in growth med-
ium (Neurobasal, 2% FBS, B27 supplement, 20 mM L-glutamine,
50 U/ml IFNc, Pen/strep antibiotics) at 33 C. To generate spheres,
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nate expression of the temperature-sensitive inducible SV40 large
T-antigen in serum free Neurobasal medium, supplemented with
B27, G5 and 20 mM L-glutamine with ﬁnal concentrations of EGF
and FGF2 at 20 ng/ml and cultured at 39 C for 5 days (Fig. 5). Un-
less otherwise speciﬁed, cell culture reagents and supplements
were from Gibco/Invitrogen (Carlesbad, CA) and growth factors/
cytokines (EGF, FGF2 and IFNc) were from PeproTech (Rock Hill,
NJ).
2.2. Animals and retinal dissection
All animals were handled in accordance with the Animal Care
Policies of the University of Houston and the ARVO Statement for
the Use of Animals in Ophthalmic and Vision Research. Mice were
maintained in a 12-h dark/12-h light cycle with food and water
ad libitum. Adult animals were euthanized by halothane inhalation,
followed by cervical dislocation; P0 animals were euthanized by
hypothermia followed by decapitation. For collection of embryonic
day 17.5 (E17.5) retinas, mice were mated overnight; the presence
of vaginal plug was marked as E0.5. For P0 eyes used for isolating
nasal/temporal and dorsal/ventral retinal samples, the ocular ori-
entation was marked with ink prior to enucleation. Following enu-
cleation, eyes were rinsed twice in 70% ethanol, followed by two
rinses in sterile PBS prior to removal of the anterior segment. The
eyecup was placed in pre-warmed CO2 independent medium and
the anterior chamber was removed. For isolation of whole retina
(E17.5, P0 and 8 months), the retina dissected free of the pig-
mented epithelium. For analysis of spatial expression and DNA
methylation, the eyecup was cut into thirds on either side of the
optic nerve head and retina dissected free of the pigmented epithe-
lium. To obtain the nasal and temporal retinal samples, the cuts
were along dorsal/ventral axis. To obtain the dorsal and ventral ret-
inal samples, the cuts were along the nasal/temporal axis.
2.3. Genomic DNA and RNA isolation
Total RNA and gDNA from retinal tissues and ImM10 cells were
isolated using AllPrep DNA/RNA columns (Qiagen; Valencia, CA).
Cells were lysed in a guanidine hydrochloride buffer, homogenized
through a 20-gauge needle and loaded onto afﬁnity columns that
retain genomic DNA, but not RNA. The ﬂow through from the ﬁrst
column containing total RNA was puriﬁed using RNeasy mini spin
columns (Qiagen; Valencia, CA), eluted in RNAse free buffer and
stored at 80 C. Genomic DNA retained in the ﬁrst column was
washed and eluted in Tris buffer and stored at 20 C. Nucleic
acids were quantiﬁed by spectrophotometry (Nanodrop; Thermo-
Scientiﬁc, Wilmington, DE) and RNA quality was assessed using
an RNA 6000 NanoChip on a Bioanalyzer 2100 (Agilent Technolo-
gies, Santa Clara, CA).
2.4. Cloning and in vitro methylation of EphA5 promoter
The EphA5 promoter region from 1552 to +997 bp relative to
the transcription start site was PCR ampliﬁed from mouse genomic
DNA using Pfx Taq polymerase (Invitrogen, Carlsbad, CA). Primers
used are listed in Supplementary Table S1. The amplicon was sub-
cloned into pCR2.1-topo (Invitrogen) and sequence veriﬁed. For
subcloning into pGL2 basic, the insert was isolated by digestion
with NotI, overhangs were ﬁlled in using DNA polymerase, Klenow
fragment and re-digested with Acc65I. Following gel puriﬁcation,
the insert was directionally cloned into pGL2-basic that had been
linearized with BglII, ﬁlled in with Klenow and re-digested with
Acc65I. For subcloning into the CpG-free, pCpGL-basic luciferase
vector (Klug & Rehli, 2006), the insert was excised from the pGL2plasmid using Acc65I/BamHI and directionally cloned into
Acc65I/BamHI digested pCpGL-basic.
For methylation analysis, plasmid DNA (4 lg) was methylated
with SssI, HhaI, and/or HpaII methyltransferase enzymes (3 U/lg
DNA, Promega; San Luis Obispo, CA) in the presence of 160 lM
S-adenosylmethionine (SAM) for 4 h at 37 C. Mock methylated
DNA was treated as above, without addition of the methyltransfer-
ase enzyme. DNA was ethanol precipitated and completeness of
methylation was veriﬁed by restriction enzyme digestion using
methylation sensitive HhaI, HpaII and BstUI and methylation
insensitive MspI.
2.5. Luciferase assays
For luciferase assays experiments, R28 cells were seeded at
160,000 cells/well in a 24-well plate and incubated for 24 h. Cells
were then transfected with 0.1, 0.25 or 0.5 lg luciferase reporter
vector and 20 ng Renilla-luciferase control vector using Lipofect-
amine LTX reagent (Invitrogen; Carlsbad, CA). After 48 h incuba-
tion, cells were lysed in passive lysis buffer and lysates were
assayed for ﬁreﬂy and pRL-Renilla luciferase activity using Dual-
Luciferase Reporter System (Promega; San Luis Obispo, CA) on a
20/20n Luminometer (Promega Corp., Sunnyvale, CA). Fireﬂy lucif-
erase activity of individual samples was normalized to Renilla
luciferase activity to correct for variation in transfection efﬁciency
between samples. Each condition was tested in triplicate and the
entire experiment was repeated three times.
2.6. Quantitative RT-PCR
For each sample, RNA was assayed by quantitative RT-PCR
(qRT-PCR) todetermineexpression levels ofEphA5mRNAusinggene
speciﬁc primers (Supplementary Table S1). For mRNA analysis,
500 ng of total RNA were reverse transcribed using Afﬁnity Script
Reverse Transcription kit (Stratagene; La Jolla, CA). cDNA was
diluted 1:20 and processed in triplicate reactions for qRT-PCR using
SYBR Green QRT-PCR 2 step kit (Stratagene; La Jolla, CA) on a Strata-
geneMX3500 real-time PCR instrument. Ct values were normalized
to housekeeping gene (Rplp0, acidic ribosomal phosphoprotein P0)
(Simpson, Feeney, Boyle, & Stitt, 2000). To compare mRNA expres-
sion between the experimental groups, relative quantities were
calculated using the DDCt-method using Relative Expression
Software Tool (REST, http://www.gene-quantiﬁcation.de) (Pfafﬂ,
Horgan, & Dempﬂe, 2002). For qRT-PCR analysis, three biological
replicates were analyzed for each sample.
2.7. Bisulﬁte sequencing
Mouse genomic DNA (gDNA) was bisulﬁte converted using DNA
EZmethylation Gold kit (Zymo Research; Orange, CA) according to
manufacturer’s recommendations. Brieﬂy, 500 ng of gDNA were
treated with CT conversion reagent at 98 C for 10 min and 64 C
for 2.5 h, followed by puriﬁcation and desulphonation. gDNA was
eluted with 10 ll of M-elution buffer, quantiﬁed by spectropho-
tometry (NanoDrop, ThermoScientiﬁc, Wilmington, DE) and stored
at 80 C. PCR primers were designed for bisulﬁte converted DNA
using Methprimer (http://www.urogene.org/methprimer/index1.
html) (Li & Dahiya, 2002) for EphA5, EphB2 and H19 (Supplementary
Table S1). Primer speciﬁcity for bisulﬁte converted DNA was veri-
ﬁed by PCR ampliﬁcation of methylated and unmethylated, bisul-
ﬁte converted plasmid DNA. Target sequences were ampliﬁed
with two rounds of hot start PCR reaction using nested primers
with Red Taq Genomic DNA Polymerase (Sigma; St. Louis, MO).
The following cycling conditions were used: 2 min at 94 C, 35 cy-
cles (30 s at 94 C, 30 s at 52 C, 2 min at 68 C), 5 min at 68 C.
Amplicons were puriﬁed using PCR afﬁnity columns (QIAquick
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(Invitrogen; Carlsbad, CA), transformed into E. coli (DH5-alpha)
and grown on LB agar plates containing kanamycin with X-gal/
IPTG blue/white selection. For each condition, at least 10 isolated
colonies were picked and sequenced (Macrogen USA, MD). Se-
quences were compiled and compared using Quantiﬁcation tool
for Methylation Analysis QUMA (http://quma.cdb.riken.jp/)
(Kumaki, Oda, & Okano, 2008). Clones with less than 95% C to T
conversion of non-CpG cytosine residues were excluded from anal-
ysis based on incomplete bisulﬁte conversion. For methylation
analysis of retinal samples, two biological replicates were
analyzed. For methylation analysis of ImM10 cells, one biological
sample was analyzed for each condition.Fig. 2. Activity of EphA5 promoter in R28 cells. R28 rat retinal progenitor cells were
transiently co-transfected with EphA5-luciferase constructs or pGL2 basic (0.1, 0.25
or 0.5 lg per well) and Renilla-luciferase control plasmids (0.01 lg per well) and
assayed after 48 h. For each, relative luciferase was calculated as the ratio of
luciferase to co-transfected Renilla luciferase for each well and expressed as fold-
change from promoterless pGL2 basic at 0.1 lg/well. Bars show mean relative
luciferase of three replicate experiments, with each condition tested in duplicate at
each concentration of plasmid. Error bars show the standard error of the mean.2.8. MMT assays for AzadC cytotoxicity
Cytotoxic assay was performed to determine the concentration
of AzadC that leads to demethylation with minimum cell death.
ImM10 cells were seeded at 7500 cells/well onto 96 well plates
in sphere forming medium and incubated overnight at 39 C. Qua-
druplicate wells were treated with 0, 1, 2, 5, 10, 20, 50, 100, or
500 lM ﬁnal concentration of 5-aza-2-dioxicytidine (AzadC, Sig-
ma, St. Louis, MO), with daily 100% media changes to insure the
presence of active AzadC. After a total incubation time of 72 h,
Methylthiazolyldiphenyl-tetrazolium bromide (MTT) reagent was
added (20 ll at 5 mg/ml), incubated for 3.5 h at 39 C. The media
was removed and reactions were terminated by addition of
150 ll of stopping solution (4 mM HCl in isopropanol) and forma-
zan crystals were dissolved by pipetting. Absorbance was mea-
sured at 590 nm with reference ﬁlter 635 nm using (FLUOstar
Omega, BMG Labtech) and the adjusted optical density value (OD
at 590 nm minus OD at 635 nm) was plotted vs. concentration of
AzadC (Supplementary Fig. S1).2.9. AzadC assays of ImM10 cells
ImM10 cells were grown to conﬂuence in growth medium in
100 mm culture plates, harvested by trypsinization and split 1:3
into 100 mm culture plates in sphere forming media under non-
immortalizing conditions and incubated overnight at 39 C (Sec-
tion 2.1 for culture media). Cells were treated with AzadC (1 or
10 lM ﬁnal concentration) or vehicle (PBS) for 72 h, with daily
100% media changes to insure the activity of the AzadC. At 72 h,
cells were harvested for combined genomic DNA and RNA extrac-
tion and analysis.Fig. 1. Organization of mouse EphA5 promoter and exon 1. The thick gray bar shows the r
spanning the transcription start site (CpG:49, containing 49 CpG dinucleotides) and the E
CpG:49 island, from was analyzed by bisulﬁte sequencing. Histograms show the % GC fro
line shows position on mouse Chromosome 5. Note that the orientation is reversed rel
Adapted from UCSC Genome Browser [http://genome.ucsc.edu/].3. Results
3.1. Cloning and sequence analysis of EphA5 promoter
ThemouseEphA5gene is locatedonchromosome5qE1 ina region
of synteny with human chromosome 4 and, like the human gene,
contains two CpG islands (Fig. 1). The ﬁrst spans the transcription
start site [327 to +387 relative to the transcription start site
(TSS)] and contains 65.1%GCwith an observed to expectedCpG ratio
of 0.839. The second is in the coding region of EphA5 exon 1 and
extends into intron 1 (+557 to +1348 relative to the TSS) with a CG
content >58.5% and an observed to expected ratio of CpG dinucleo-
tides of 0.622. We have cloned the mouse EphA5 promoter from
1556 to +997base pairs relative to the transcription start site, from
mouse genomic DNA. This region includes a proximal conserved
region surrounding the transcription start site andadistal conserved
region located between 1200 and 1500 bp. We tested the EphA5
promoter activity in mouse R28 rat retinal progenitor cells using
luciferase assays. Themouse EphA5 promoterwas active in R28 cells
(Fig. 2), consistent with RT-PCR analysis that showed that R28 cells
expressed EphA5 (data not shown).
3.2. EphA5 expression and promoter methylation in the retina
To determine whether there are developmental (age-related) or
spatial (nasal vs. temporal; dorsal vs. ventral) differences in CpGegion of EphA5 (1556 to +997) cloned and analyzed in luciferase assays. CpG islands
xon1/intron 1 boundary (CpG:29, containing 29 CpG dinucleotides are stippled. The
m 40% to 100% calculated in 5 bp windows and mammalian conservation. The upper
ative to the genome sequence to show the gene in the standard 50–30 orientation.
Fig. 3. EphA5 methylation levels and mRNA expression in E17.5, P0 and adult
mouse retina. (A) Graphs showing mean relative EphA5mRNA expression from qRT-
PCR analysis normalized to E17.5. Relative expression was unchanged at P0
(0.95 ± 0.18) and but decreased by 0.735 ± 0.1 (*p = 0.05) at 8 months. (n = 3, error
bars = standard error of the mean). (B) Methylation frequency of EphA5 CpG island
shown in bubble diagrams for E17.5, P0 and adult (8 months) mouse retinas. Each
line represent a clone, circles show CpG dinucleotides. Open circles = unmethylated,
black circles = methylated. Retinal CpG methylation in the EphA5 CpG island was
1.2 ± 0.28% for both E17.5 and 8 months, 1.6 ± 0.46% for P0. Differences in
methylation frequency between the three age groups were not statistically
signiﬁcant. Numbers at the bottom show the position of the CpG island in base
pairs relative to the transcription start site (TSS, arrow).
Fig. 4. EphA5 mRNA expression and CpG methylation in nasal/temporal and dorsal
ventral mouse retina. (A) Graphs showing mean relative EphA5mRNA expression in
nasal and temporal thirds of the mouse retina at P0 determined using qRT-PCR and
normalized to nasal retina. EphA5 mRNA expression was 1.47 ± 0.29-fold higher in
temporal vs. nasal (*p = 0.02). (B) Graphs showing mean relative EphA5 mRNA
expression in dorsal and ventral thirds of the mouse retina at P0 determined using
qRT-PCR and normalized to dorsal retina. EphA5 mRNA expression was 1.15 ± 0.0-
fold higher in the ventral vs. dorsal retina (p = 0.32). For both A and B, three
biological replicates were analyzed, with each sample analyzed in triplicate. Error
bars = standard error of the mean. (C) Methylation frequency of EphA5 CpG island
shown in bubble diagrams for nasal, temporal, dorsal and ventral thirds of mouse
retina at P0. Each line represent a clone, circles show CpG dinucleotides. Open
circles = unmethylated, black circles = methylated. The EphA5 CpG island spanning
the transcription start site (485 bp) was ampliﬁed from bisulﬁte converted gDNA in
a nested PCR. EphA5 CpG methylation at P0 varied topographically. The highest CpG
methylation was in the nasal retina (3.29 ± 0.84%), compared to temporal
(1.5 ± 0.46%; p = 0.01 vs. nasal). Dorsal retina (0.63 ± 0.21%) and ventral retina
(0.28 ± 0.7%) had minimal methylation and differences between dorsal and ventral
were not statistically signiﬁcant (p = 0.32). Numbers at the bottom show the
position of the CpG island in base pairs relative to the transcription start site (TSS,
arrow).
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relative to TSS) by bisulﬁte sequencing of genomic DNA from the
mouse retina and compared this to differences in mRNA expres-
sion. By quantitative RT-PCR, there was a small, but progressive de-
cline in EphA5 mRNA expression with age (Fig. 3A). Relative to
E17.5, EphA5 expression was unchanged at post-natal day 0 (P0)
and decreased by 26% at 8 months (p = 0.05). Despite the decrease
in EphA5 mRNA expression, CpG methylation of EphA5 was un-
changed. Overall methylation was 1.2 ± 0.3% at E17.5, 1.6 ± 0.5%
at P0, 1.2 ± 0.3% for PM8 (Fig. 3B) with no statistically signiﬁcant
differences.
Dissection of retina into thirds at P0 revealed that the distribu-
tion of cells showing methylation of the EphA5 promoter in the ret-
ina was highly unequal. For dorso-ventrally dissected retina, of
which only the dorsal and the ventral thirds were analyzed, the to-
tal methylation level detected was below 1% in both the dorsal and
ventral retina (Fig. 4C). There were no differences in methylation
levels between the two domains (p = 0.32 dorsal vs. ventral). Incontrast, for nasal-temporally dissected retina, of which only the
nasal and the temporal thirds were analyzed, the overall methyla-
tion level was higher (Fig. 4C). This indicates that methylated cells
were preferentially localized to the median third of the retina, as
opposed to the dorsal/ventral domains and, within this third,
methylation frequency was highest in the nasal portion (p = 0.01
vs. temporal). Signiﬁcant up-regulation of EphA5mRNA expression
was observed only in the temporal third of nasal-temporally
Fig. 5. Effects of differential methylation on EphA5 promoter activity in vitro. The
EphA5 promoter, subcloned in CpG-free CpGL luciferase reporter (gray bars), was
methylated in vitro prior to transient transfection of R28 rat retinal cells. Expression
levels are expressed relative to the empty CpGL vector (black bar) and variation in
transfection efﬁciency was normalized by expression of co-transfected Renilla-
luciferase control plasmids (0.01 lg per well). Bars show mean relative luciferase of
three replicate experiments, with each condition tested in duplicate at each
concentration of plasmid. Error bars show the standard error of the mean.
Unmethylated EphA5-CpGl plasmid (Mock) was incubated in parallel with meth-
ylation reactions but without methyltransferase enzymes. SssI, methylates 98 CpGs
and reduced EphA5 promoter activity by 92% (p < 0.0001) to level comparable to
CpGL-basic. HhaI methylates 10 CpGs and decreased activity by 20% (p = 0.03).
HpaII methylates six CpGs and increased promoter activity by 35% (p = 0.01 vs.
Mock). The combination of HhaI and HpaII methylates 16 CpGs and increased
activity by 38% (p = 0.002 vs. Mock).
T.D. Petkova et al. / Vision Research 51 (2011) 260–268 265dissected retina (Fig. 4A), while there were no signiﬁcant differ-
ence in EphA5 mRNA expression between the dorsal or ventral
thirds (Fig. 4B).3.3. Effects of methylation of EphA5 promoter
To assess the effects of methylation on promoter activity, the
EphA5 promoter (1552 to +997 bp) was subcloned into a CpG free
luciferase vector, pCpGL and methylated by SssI methyltransferase.
SssI methylates 98 CpG sites within the EphA5 promoter and re-
duced activity of the pCpGL-EphA5 construct by 92% (p < 0.0001)
(Fig. 5). Because total methylation is well known to silence gene
expression and we had only observed low levels of EphA5 promoter
methylation in the retina, we tested whether lower levels of CpG
methylation could also silence the EphA5 promoter. The pCpGL-
EphA5 construct was methylated with HhaI methyltransferase,
which methylates 10 CpG sites (CGCG) and/or HpaII methyltrans-
ferase, which methylates six CpG sites (CCGG) within the EphA5
promoter (Fig. 5). When compared to mock methylated construct,
HhaI decreased promoter activity by 20% (p = 0.032). Surprisingly,
HpaII methylation resulted in a 35% increase (p = 0.008) of EphA5
promoter activity and constructs methylated with both HhaI and
HpaII methyltransferases continued to show increased activity
(38%, p = 0.002 vs. mock-methylated control). Thus, whereas the
EphA5 promoter was completely silenced by total methylation of
all CpG dinucleotides, introducing low levels of site-speciﬁc CpG
methylation in the EphA5 construct could elicit either increased
or decreased promoter activity, depending on the methylated sites.3.4. mRNA expression and methylation of EphA5 and EphB2 in ImM10
Müller glia
Our lab has been investigating the neurogenic potential of
Müller glia and have generated a conditionally immortalized
mouse Müller glia cell line (ImM10) (Otteson & Phillips, 2010) that
can generate spheres similar to neurospheres following EGF/FGF2
stimulation (Fig. 6A). For ImM10 cells and other Müller glia to beuseful as potential sources of retinal stem cells for regeneration,
they need to retain the ability to up-regulate and express genes
necessary for neuronal differentiation. First, we asked if ImM10
cells expressed Eph receptors. By qRT-PCR, EphA5 receptor is
weakly expressed (average Ct value, 38 cycles) in ImM10 cells,
but was undetectable in sphere cultures (Fig. 6B). Bisulﬁte
sequencing showed hypermethylation of the EphA5 promoter
methylation in ImM10 under immortalizing conditions (49.6%)
and sphere cultures under non-immortalizing conditions (47.8%)
(Fig. 6E). The difference in methylation between the two culture
conditions was not statistically signiﬁcant (p = 0.5805). To deter-
mine whether increased DNA methylation and transcriptional
silencing were general characteristics of all Eph receptor genes in
ImM10 cells, we also analyzed expression and methylation of
EphB2. EphB2 was expressed in ImM10 cells in both growth and
sphere cultures and was unmethylated (Fig. 6F).3.5. Effects of demethylation of ImM10 cells using AzadC
If DNA methylation is repressing EphA5 in ImM10 cells, then
demethylation should permit up-regulation of expression. We
tested multiple concentrations of AzadC for cytotoxicity in
ImM10 cells using MTT assays and found minimal effects up to
100 lM (Supplementary Fig. S1). We then tested the efﬁcacy of
AzadC demethylation of H19, a paternally imprinted gene that is
known to be demethylated by AzadC treatment (El Kharroubi,
Piras, & Stewart, 2001). By bisulﬁte sequencing, 1 or 10 lM AzadC
treatment resulted in a systematic and statistically signiﬁcant
demethylation of H19 (Supplementary Fig. S2), therefore, we used
these concentrations for our analysis. Sphere cultures of ImM10
cells treated with AzadC showed a signiﬁcant decrease in DNA
methylation of 25.4 ± 2.9% (1 lM, p = 0.01) or 24.5 ± 6.1% (10 lM,
p = 0.001) (Fig. 6E) and an up-regulation of EphA5 mRNA expres-
sion by 99.2 ± 6.1 or 94.6 ± 11.2-fold, respectively compared to un-
treated controls (Fig. 6B and C). Following AzadC treatment, no
obvious changes in cell morphology or in the size of the spheres
were observed. Spheres remained non-adherent with no migration
of cells out of the spheres during the 72 h treatment period. To look
for possible non-speciﬁc effects of AzadC treatment on gene
expression, we also analyzed methylation and expression of EphB2
and found that AzadC treatment had no effect on methylation lev-
els or expression of EphB2 (Fig. 6B, D, F).4. Discussion
We report here the cloning of the mouse EphA5 promoter and
provide evidence for a potential role for DNA methylation in mod-
ulating EphA5 gene expression in the retina in vivo and a clear role
for DNA methylation in silencing EphA5 expression in ImM10 Mül-
ler glia in vitro. Global genome-wide DNA methylation changes
with age with a tendency towards hypermethylation in many
genes (Gravina & Vijg, 2010). However, we did not detect any
changes in overall DNA methylation in genomic DNA from whole
retinas even at 8 months of age. In contrast, there were topo-
graphic differences at P0, prior to reﬁnement and pruning of axon
terminals and the wave of programmed cell death of RGCs (Farah &
Easter, 2005; O’Leary & McLaughlin, 2005). However, there was a
modest increase in methylation the nasal retina in CpG sites imme-
diately downstream of the transcription start site. The increased
methylation corresponded to decreased mRNA expression in the
nasal retina suggesting a potential regulatory role for methylation
in modulating EphA5 expression. Total DNA methylation results in
chromatin compaction, blocking transcription factor binding and
recruitment of methyl binding proteins which assist in the
deacetylation of histones, although reports regarding the precise
Fig. 6. Effects of AzadC on EphA5 and EphB2 expression and promoter methylation in ImM10 cells. In the left panel, ImM10 cells cultured in immortalizing conditions (growth
medium, with 50 U/ml interferon gamma at 33 C) are adherent with a typical glial morphology, In the right panel, ImM10 cells cultured for 7 days in non-immortalizing
conditions in sphere medium containing 20 ng/ml EGF, FGF2 form non-adherent spheres. Scale bar = 100 lm in both panels. (B) Ethidium bromide stained gel of amplicons
from qRT-PCR analysis EphA5 and EphB1 expression in ImM10 cell under growth conditions (Müller), non-immortalizing sphere conditions (sphere) and in adult mouse retina
(retina). Right panel shows amplicons from sphere cultures following 72 h of AzadC treatment at 1 and 10 lM. Rplp0 was used as a normalizing gene. (C) Graphs showing
quantitative analysis of qRT-PCR results for EphA5 in sphere cultures with (gray bars) and without (black bars) AzadC treatment. (D) Graphs showing quantitative analysis of
qRT-PCR results for EphB2 in sphere cultures with (gray bars) and without (black bars) AzadC treatment. Note that the scale of the Y-axis differs in C and D. (E) Methylation
frequency of EphA5 CpG island shown in bubble diagrams. ImM10 cells in growth/immortalizing conditions (Müller glia) were 49.6 ± 7.64% methylated. ImM10 cells in non-
immortalizing sphere cultures (spheres) were 47.8 ± 7.6% methylated. Methylation frequency was 25.4 ± 2.9% following 1 lM AzadC (p = 0.01 vs. control) and 24.5 ± 6.1%
following 10 lM AzadC (p = 0.01 vs. control). (F) EphB2was essentially unmethylated in all conditions tested. Note that analysis of gene expression and methylation of EphA5
and EphB2 was performed on DNA and RNA isolated from the same biological samples. Arrows indicate position of transcription start sites (TSS).
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(Vaissiere, Sawan, & Herceg, 2008). In contrast, site-speciﬁc meth-
ylation can alter binding afﬁnities of speciﬁc transcription factors
which can differentially activate or repress transcription (Cao, Jean,
& Williams, 2000). Consistent with this, we showed that although
methylation of all CpG sites resulted in silencing of EphA5 pro-
moter activity, lower levels of methylation resulted in differential
activation or repression of EphA5 promoter activity, depending
on the sites methylated. The observation that promoter repression
by HpaII methylation could not overcome promoter activation by
HhaI methylation suggests that inactivation of potential repressor
elements in the promoter through DNA methylation is likely to ex-
ert stronger control on transcription than loss of positive regula-
tory elements.
Most of the proposed transcriptional regulators of EphA5,
including HMX1, FOXD1 and FOXG1, bind to AT rich sites that lack
CpG dinucleotides (Amendt, Sutherland, & Russo, 1999; Obendorf
et al., 2007; Zhang et al., 2003) and are therefore unlikely to be di-
rectly affected by methylation of their consensus binding sites. Zic2binds to a GC-rich consensus site and has been implicated as a reg-
ulator of EphB1 (Herrera et al., 2003). Although the identity of other
regulatory targets for ZIC2 in the retina remains undetermined, we
have identiﬁed several potential ZIC2 binding sites in the EphA5
promoter. Interestingly, ZIC2 can displace SP1 and SP3 at consen-
sus binding sites in D(1A) dopamine receptor promoter to block
Sp1-mediated transactivation (Yang, Hwang, Junn, Lee, &Mouradian,
2000). Sp1 and Sp3 are members of the larger Sp/Klf family of tran-
scription factors that can recognize similar CG rich consensus sites
and either activate or repress transcription, depending on the pro-
moter context (Kaczynski, Cook, & Urrutia, 2003). There are multi-
ple predicted binding sites for Sp/Klf factors in the EphA5 promoter
and SP1/SP3 sites coincide with seven of the HhaI sites and four of
the HpaII methylation sites (Supplementary Table S2). DNA meth-
ylation has variable effects on SP1 binding and in some genes,
methylation in ﬂanking sequences can decrease SP1/SP3 binding
(Zhu et al., 2003). Interestingly, T 1a, a gene expressed in lung
but not in brain, can be silenced in the brain by methylation of a
single SP1/3 binding site (Cao et al., 2000). Fourteen of the
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and P0 and over-expression of speciﬁc Klf cDNAs in RGCs differen-
tially promotes axon outgrowth or retraction (Moore et al., 2009).
Thus, methylation of GC-rich consensus binding sites, potentially
for ZIC2 or SP/KLF transcription factors, could alter binding afﬁnity
of transcription factors for speciﬁc sites, resulting in modulation
EphA5 promoter activation or repression.
We used genomic DNA and RNA isolated from whole retinas for
our analyses. Therefore, although we saw subsets of clones with
potentially interesting patterns of methylation, attributing a par-
ticular methylation pattern to a speciﬁc cell type within the retina
is not possible. However, we can draw some inferences based on
the populations present at the time points analyzed. Since progen-
itor cells constitute a large fraction of all cells present in the E17.5
and P0 retinas, we infer that EphA5 is largely unmethylated in both
early and late-stage retinal progenitors. At 8 months, rod photore-
ceptors are the single most abundant cell types in the retina, thus,
we infer that EphA5 remains unmethylated in rod photoreceptors.
However, in the mature mouse retina, Müller glia and RGC respec-
tively constitute 3% and <1.3% of all retinal cells (Jeon, Strettoi, &
Masland, 1998). Thus, even with a sampling depth of 20 clones, we
would expect, on average, that less than one clone would represent
genomic DNA from Müller glia or retinal ganglion cells. Therefore,
the patterns of DNA methylation and the potential role for methyl-
ation in regulating EphA5 expression speciﬁcally in RGCs or Müller
cells in vivo will require analysis of pure cell populations.
There is evidence supporting a role for DNA methylation in dis-
regulation of EphA5 and expression of other Eph receptor in cancer
(Dottori et al., 1999; Fu et al., 2010; Kalinski et al., 2009; Kuang
et al., 2010; Merlos-Suarez & Batlle, 2008; Wang et al., 2005). De-
creased EPHA5 mRNA expression is associated with increased pro-
moter methylation in human primary breast cancer (Fu et al.,
2010). In cancer cells, AzadC can reverse DNA hypermethylation
and re-establish patterns of gene expression typical of non-cancer-
ous cells (Bird, 2002). Our results showing decreased methylation
and up-regulation of EphA5 in ImM10-derived sphere cultures fol-
lowing AzadC treatment are consistent with the up-regulation of
EphA5 following AzadC demethylation in mammary tumor cell
lines (Fu et al., 2010). Our results support a role for DNA methyla-
tion in silencing EphA5 and suggest a potential mechanism for
silencing other developmentally important genes in Müller glia-
derived spheres.
Methylation analysis of freshly isolated and cultured cells has
shown that global methylation patterns are maintained in long-
term cultures, although there are changes in speciﬁc CpG sites, par-
ticularly in genes involved in differentiation (Bork et al., 2010).
SV40 transformed cell lines are known to have increased levels
of DNA methylation (Liu et al., 2005). The conditional immortaliza-
tion of Müller glia with the tsA58-SV40 transgene (Jat et al., 1991)
could contribute to the increased methylation of EphA5 in ImM10
cells. However, increased methylation in this cell line is clearly
gene speciﬁc, as EphB2 was found to be essentially unmethylated
in ImM10 cells under both immortalizing and non-immortalizing
(sphere forming) conditions. It will be important to determine
whether silencing of EphA5 by methylation is a general character-
istic of Müller glia, both in vitro and in vivo, and whether other
developmentally critical genes are also silenced by DNA methyla-
tion in Müller glia.
Müller glia have been proposed as a possible source of stem-like
cells that could be used for regenerative strategies in the retina
(Jadhav, Roesch, & Cepko, 2009; Karl et al., 2008). During
retinal development, Müller glia are generated from late-stage
progenitors and both cell types express many of the same genes
(Blackshaw et al., 2004; Otteson & Phillips, 2010; Roesch et al.,
2008), yet their ability to de-differentiate and generate retinal neu-
rons remains limited at best, both in vivo and in vitro (Karl et al.,2008; Lawrence et al., 2007). Removal of epigenetic marks, includ-
ing DNA and histone methylation, induces re-expression of
pluripotency-associated genes in somatic cells (Bian, Alberio,
Allegrucci, Campbell, & Johnson, 2009; Miyamoto et al., 2009)
and in brain-derived neurospheres (Ruau et al., 2008). Our results
point to a possible role for chromatin remodeling in silencing of
developmentally important genes in Müller glia. Although we did
not observe any morphological changes in the EGF/FGF2 induced
sphere cultures following demethylation, this is not entirely unex-
pected given the short time-course of the treatment and the fact
that we did not switch the cells to differentiation media that can
induce up-regulation of some neuronal genes in vitro. It will be
interesting to determine which other neuronal genes are silenced
by methylation in Müller glia and whether hypermethylation is a
general characteristic of all Müller glial cell lines and of primary
Müller glia. The ﬁnding that demethylation promotes re-expres-
sion of EphA5 in ImM10 cells suggests that AzadC treatment may
be a useful approach for increasing the neurogenic potential of
Müller glia in vitro and in vivo.Acknowledgments
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